Frequent Alterations of Smad Signaling in Human Head and Neck Squamous Cell Carcinomas: A Tissue Microarray Analysis

Oncology Research

Volumn 14, Issue 2, 2003, Pages 61-73

  Xie, Wen ^a   Bharathy, Savita ^a   Kim, David ^b   Haffty, Bruce G ^b   Rimm, David L ^b   Reiss, Michael ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Head and neck cancer; Smad; Tissue microarray; Transforming growth factor

Indexed keywords

SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CAPILLARY; CARCINOMA CELL; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROENVIRONMENT; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PSMAD2 GENE; SIGNAL TRANSDUCTION; SMAD GENE; SMAD2 GENE; SMAD3 GENE; SMAD4 GENE; SQUAMOUS CELL CARCINOMA; STROMA CELL; TUMOR CELL LINE;

EID: 0842327354     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003108748612     Document Type: Article

References (44)

1. Parkin, D. M. Global cancer statistics in the year 2000. Lancet Oncol. 2:533-543; 2001.
2. Jemal, A.; Murray, T.; Samuels, A.; Ghafoor, A.; Ward, E.; Thun, M. J. Cancer statistics, 2003. CA Cancer J. Clin. 53:5-26; 2003.
3. Percy, C. Histology of cancer-incidence and prognosis: SEER population-based data, 1973-1987. Cancer (Suppl.) 75; 1995.
4. Cui, W.; Fowlis, D. J.; Cousins, F. M.; Duffie, E.; Bryson, S.; Balmain, A.; Akhurst, R. J. Concerted action of TGF-beta I and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev. 9:945-955; 1995.
5. Glick, A. B.; Kulkarni, A. B.; Tennenbaum, T.; Hennings, H.; Flanders, K. C.; O'Reilly, M.; Sporn, M. B.; Karlsson, S.; Yuspa, S. H. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA 90:6076-6080; 1993.
6. Glick, A. B.; Weinberg, W. C.; Wu, I. H.; Quan, W.; Yuspa, S. H. Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb. Cancer Res. 56:3645-3650; 1996. [Published erratum appears in Cancer Res. 57(10):2079; 1997].
7. Glick, A. B.; Weinberg, W. C.; Wu, I. H.; Quan, W.; Yuspa, S. H. Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb. Cancer Res. 56:3645-3650; 1996. [Published erratum appears in Cancer Res. 57(10):2079; 1997].
8. Massague, J.; Chen, Y.-G. Controlling TGF-β signaling. Genes Dev. 14:627-644; 2000.
9. Yu, L.; Hebert, M. C.; Zhang, Y. E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21:3749-3759; 2002.
10. Abdollah, S.; Macias-Silva, M.; Tsukazaki, T.; Hayashi, H.; Attisano, L. ; Wrana, J. L. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272:27678-27685; 1997.
11. Souchelnytskyi, S.; Tamaki, K.; Engstrom, U.; Wernstedt, C.; ten Dijke, P.; Heldin, C. H. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem. 272:28107-28115; 1997.
12. Pierreux, C. E.; Nicolas, F. J.; Hill, C. S. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol. Cell Biol. 20: 9041-9054; 2000.
13. Xu, L.; Kang, Y.; Col, S.; Massague, J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol. Cell. 10:271-282; 2002.
14. Inman, G. J.; Nicolas, F. J.; Hill, C. S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol. Cell 10:283-294; 2002.
15. Massague, J.; Wotton, D. Transcriptional control by the TGFβ/Smad signaling system. EMBO J. 19:1745-1754; 2000.
16. Attisano, L.; Wrana, J. L. Smads as transcriptional comodulators. Curr. Opin. Cell Biol. 12:235-243; 2000.
17. Yagi, K.; Furuhashi, M.; Aoki, H.; Goto, D.; Kuwano, H.; Sugamura, K.; Miyazono, K.; Kato, M. c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277: 854-861; 2002.
18. Seoane, J.; Pouponnot, C.; Staller, P.; Schader, M.; Eilers, M.; Massague, J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3:400-408; 2001.
19. Hébert, C. D.; Birnbaum, L. S. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor β in human squamous carcinoma cell lines. Cancer Res. 49:3196-3202; 1989.
20. Reiss, M.; Stash, E. B. High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor-β. Cancer Commun. 2:363-369; 1990.
21. Briskin, K. B.; Fady, C.; Mickel, R. A.; Wang, M.; Lichtenstein, A. Inhibition of head and neck squamous cell carcinoma cell lines by transforming growth factor-beta. Otolaryngol. Head Neck Surg. 112:728-734; 1995.
22. Yan, W.; Vellucci, V. F.; Reiss, M. Smad protein expression and activation in transforming growth factor-beta refractory human squamous cell carcinoma cells. Oncol. Res. 12:157-167; 2000.
23. Garrigue-Antar, L.; Munoz-Antonia, T.; Antonia, S. J.; Gesmonde, J.; Vellucci, V. F.; Reiss, M. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55:3982-3987; 1995.
24. De, M.; Yan, W.; de Jonge, R. R.; Garrigue-Antar, L.; Vellucci, V. F.; Reiss, M. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer. Cancer Res. 58:1986-1992; 1998.
25. Eisma, R. J.; Spiro, J. D.; von Biberstein, S. E.; Lindquist, R.; Kreutzer, D. L. Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells. Am. J. Surg, 172:641-645; 1996.
26. Wang, D.; Song, H.; Evans, J. A.; Lang, J. C.; Schuller, D. E.; Weghorst, C. M. Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis 18:2285-2290; 1997.
27. Muro-Cacho, C. A.; Anderson, M.; Cordero, J.; Munoz-Antonia, T. Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma. Clin. Cancer Res. 5:1243-1248; 1999.
28. Muro-Cacho, C. A.; Rosario-Ortiz, K.; Livingston, S.; Munoz-Antonia, T. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Clin. Cancer Res. 7:1618-1626; 2001.
29. Chen, T.; Yan, W.; Wells, R. G.; Rimm, D. L.; McNiff, J.; Leffell, D.; Reiss, M. Novel inactivating imitations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases. Int. J. Cancer 93:653-661; 2001.
30. Pirisi, L.; Yasumoto, S.; Feller, M.; Doniger, J.; DiPaolo, J. A transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61:1061-1066; 1987.
31. Kononen, J.; Bubendoff, L.; Kallioniemi, A.; Barlund, M.; Schraml, P.; Leighton, S.; Torhorst, J.; Mihatsch, M. J.; Sauter, G.; Kallioniemi, O. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4:844-847; 1998.
32. Camp, R. L.; Charette, L. A.; Rimm, D. L. Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80:1943-1949; 2000.
33. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observation. J. Am. Statist. Assoc. 53:457-481; 1958.
34. Parekh, T. V.; Gama, P.; Wen, X.; Demopoulos, R.; Munger, J. S.; Carcangiu, M. L.; Reiss, M.; Gold, L. I. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Cancer Res. 62:2778-2790; 2002.
35. Xie, W.; Mertens, J. C.; Reiss, D. J.; Rimm, D. L.; Camp, R. L.; Haffty, B. G.; Reiss, M. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome-A tissue microarray study. Cancer Res. 62: 497-505; 2002.
36. Knobloch, T. J.; Lynch, M. A.; Song, H.; DeGroff, V. L.; Casto, B. C.; Adams, E. M.; Alam, K. Y.; Lang, J. C.; Schuller, D. E.; Weghorst, C. M. Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers. Mutat. Res. 479:131-139; 2001.
37. Wilentz, R. E.; Su, G. H.; Dai, J. L.; Sparks, A. B.; Argani, P.; Sohn, T. A.; Yeo, C. J.; Kern, S. E.; Hruban, R. H. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation. Am. J. Pathol. 156:37-43; 2000.
38. Wilentz, R. E.; Iacobuzio-Donahue, C. A.; Argani, P.; McCarthy, D. M.; Parsons, J. L.; Yeo, C. J.; Kern, S. E.; Hruban, R. H. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60: 2002-2006; 2000.
39. Garrigue-Antar, L.; Souza, R. F.; Vellucci, V. F.; Meltzer, S. J.; Reiss, M. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer. Lab. Invest. 75:263-272; 1996.
40. Xie, W.; Rimm, D. L.; Lin, Y.; Shih, W. J.; Reiss, M. Loss of Smad signaling is associated with poor outcome in human colorectal cancer. Cancer J. (in press).
41. Mu, D.; Cambier, S.; Fjellbirkeland, L.; Baron, J. L.; Munger, J. S.; Kawakatsu, H.; Sheppard, D.; Broaddus, V. C.; Nishimura, S. L. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J. Cell Biol. 157:493-507; 2002.
42. Jeruss, J. S.; Sturgis, C. D.; Rademaker, A. W.; Woodruff, T. K. Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res. 63:3783-3790; 2003.
43. Chen, T.; De Vries, E. G. E.; Hollema, H.; Yegen, H. A.; Vellucci, V. F. ; Strickler, H. D.; Hildesheim, A.; Reiss, M. Structural alterations of transforming growth factor-β receptor genes in cervical carcinoma. Int. J. Cancer 82: 43-51; 1999.
44. Kim, S. K.; Fan, Y.; Papadimitrikopoulou, V.; Clayman, G.; Hittelman, W. N.; Hong, W. K.; Lotan, R.; Mao, L. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56:2519-2521; 1996.